Drugs / BI 847325
last change Oct 2013 re-read 3 minutes ago

BI 847325

Developed for
neoplasm
Investigated by
Boehringer Ingelheim

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01324830 Apr 2011 → Jun 2013 neoplasm Boehringer Ingelheim Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BI 847325 “Monotherapy Dose Finding With BI 847325 in Solid Tumours” NCT01324830 ↗
Route Oral “Orally Administered Once a Day” NCT01324830 ↗